Cargando…
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with the pathological accumulation of lipids inside hepatocytes. Untreated NAFL can progress to non-alcoholic hepatitis (NASH), followed by fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The common denominator...
Autores principales: | Gudan, Anna, Kozłowska-Petriczko, Katarzyna, Wunsch, Ewa, Bodnarczuk, Tomasz, Stachowska, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052062/ https://www.ncbi.nlm.nih.gov/pubmed/36986052 http://dx.doi.org/10.3390/nu15061323 |
Ejemplares similares
-
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-Regression
por: Gudan, Anna, et al.
Publicado: (2022) -
Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients—Randomized Control Trials (RCT)
por: Maciejewska-Markiewicz, Dominika, et al.
Publicado: (2022) -
Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?
por: Hawryłkowicz, Viktoria, et al.
Publicado: (2021) -
Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
por: Kozłowska-Petriczko, Katarzyna, et al.
Publicado: (2021) -
What Do We Know about Nociplastic Pain?
por: Bułdyś, Kacper, et al.
Publicado: (2023)